Local Radiotherapy for Patients with newly diagnosed, metastatic Prostate Cancer

被引：0
|
作者：
Guckenberger, Matthias [1 ]
机构：
[1] Univ Hosp Zurich USZ, Competence Ctr Palliat Care, Dept Radiat Oncol, Ramistr 100, CH-8091 Zurich, Switzerland
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2019年 / 195卷 / 04期
关键词：
THERAPY; SURVIVAL;
D O I：
10.1007/s00066-019-01435-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：362 / 364
页数：3
相关论文
共 50 条
  • [21] Re: Association of Bone Metastatic Burden with Survival Benefit from Prostate Radiotherapy in Patients with Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2021, 206 (01): : 159 - 160
  • [22] Counseling patients with newly diagnosed prostate cancer
    Thompson, IM
    ONCOLOGY-NEW YORK, 2000, 14 (01): : 119 - +
  • [23] Local prostate radiotherapy in metastatic prostate cancer and symptomatic local events.
    Kwok, Jaime Kirsten
    Martell, Kevin
    Sia, Michael
    Bhindi, Bimal
    Abedin, Tasnima
    Lu, Shuang
    Quon, Harvey Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [24] Prostate radiotherapy in newly-diagnosed metastatic hormone-sensitive prostate cancer: A single-institution experience.
    Morgan, Scott Carlyle
    Holmes, Oliver
    Craig, Julia
    Grimes, Scott
    Eapen, Libni
    Malone, Shawn
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [25] Local and metastatic curative radiotherapy in patients with de novo oligometastatic prostate cancer
    C. Reverberi
    M. Massaro
    M. F. Osti
    D. Anzellini
    L. Marinelli
    A. Montalto
    V. De Sanctis
    M. Valeriani
    Scientific Reports, 10
  • [26] Local and metastatic curative radiotherapy in patients with de novo oligometastatic prostate cancer
    Reverberi, C.
    Massaro, M.
    Osti, M. F.
    Anzellini, D.
    Marinelli, L.
    Montalto, A.
    De Sanctis, V.
    Valeriani, M.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [27] Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
    Parker, Christopher C.
    James, Nicholas D.
    Brawley, Christopher D.
    Clarke, Noel W.
    Hoyle, Alex P.
    Ali, Adnan
    Ritchie, Alastair W. S.
    Attard, Gerhardt
    Chowdhury, Simon
    Cross, William
    Dearnaley, David P.
    Gillessen, Silke
    Gilson, Clare
    Jones, Robert J.
    Langley, Ruth E.
    Malik, Zafar I.
    Mason, Malcolm D.
    Matheson, David
    Millman, Robin
    Russell, J. Martin
    Thalmann, George N.
    Amos, Claire L.
    Alonzi, Roberto
    Bahl, Amit
    Birtle, Alison
    Din, Omar
    Douis, Hassan
    Eswar, Chinnamani
    Gale, Joanna
    Gannon, Melissa R.
    Jonnada, Sai
    Khaksar, Sara
    Lester, Jason F.
    O'Sullivan, Joe M.
    Parikh, Omi A.
    Pedley, Ian D.
    Pudney, Delia M.
    Sheehan, Denise J.
    Srihari, Narayanan Nair
    Tran, Anna T. H.
    Parmar, Mahesh K. B.
    Sydes, Matthew R.
    LANCET, 2018, 392 (10162): : 2353 - 2366
  • [28] Survival in men with newly diagnosed hormone sensitive metastatic prostate cancer
    Stroomberg, H. V.
    Helgstrand, J. T.
    Brasso, K.
    Roder, A.
    EUROPEAN UROLOGY, 2023, 83
  • [29] Bone Scanning in Patients with Newly Diagnosed Prostate Cancer
    Jaukovic, L.
    Ajdinovic, B.
    Dopudja, M.
    Dugonjic, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S364 - S364
  • [30] Prostate cancer survivors give advice to newly diagnosed prostate cancer patients
    Branch, L
    Erb, D
    Brown, D
    GERONTOLOGIST, 2002, 42 : 415 - 416
12345